6 Recruiting Lung Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for lung cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Cancer studiesPhase 1 / Phase 2 Studies for Lung Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
📍 City of Hope Cancer Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
📍 Stanford University — Stanford, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
📍 Royal University Hospital — Saskatoon, Saskatchewan
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
📍 St. Paul's Hospital — Saskatoon, Saskatchewan
View Study & Checklist ➔